NCT06732375

Brief Summary

The purpose of this study is to evaluate the feasibility and acceptability of the Mindset Moments™ (MM™) program in managing psychological distress and resiliency in adolescent and young adult cancer survivors. Study participation will involve attending 8 weekly, one hour, live online group sessions and completing daily 5 minute activities such as guided imageries and CBT check in within the app. Participants will also be asked to complete an online survey at the time of enrollment and at 4 and 8 weeks.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
10mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Jun 2025Mar 2027

First Submitted

Initial submission to the registry

December 10, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 13, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

June 13, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

May 6, 2026

Status Verified

December 1, 2025

Enrollment Period

1.6 years

First QC Date

December 10, 2024

Last Update Submit

May 5, 2026

Conditions

Keywords

young adult cancer survivordistressyouth cancer survivorresilience

Outcome Measures

Primary Outcomes (1)

  • Anxiety as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)

    8-measure short form to assess the severity of anxiety symptoms within the Patient-Reported Outcomes Measurement Information System (PROMIS) framework. The total score ranges from 8 to 40, where a higher score indicates greater anxiety.

    8 weeks

Secondary Outcomes (4)

  • Depression as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)

    8 weeks

  • Symptoms of Post-Traumatic Stress Disorder (PTSD) as measured by the PCL-5

    8 weeks

  • Distress as measured by the National Comprehensive Cancer Network's (NCCN) Distress Thermometer (DT)

    8 weeks

  • Ability to deal with stressful situations as measured by the Shift-and-Persist Scale

    8 weeks

Study Arms (1)

Interventional arm

EXPERIMENTAL

Study participation will involve attending 8 weekly, one hour, live online group sessions and completing daily 5 minute activities such as guided imageries and CBT (cognitive behavioral therapy) check-in within the app.

Behavioral: Mindset Moments

Interventions

Mindset MomentsBEHAVIORAL

MM™ includes: 1) CBT; 2) resilience training; 3) mindfulness-based stress reduction; 4) peer support; and 5) family conversations delivered in small virtual groups, with a "mentor" who facilitates resilience-building conversations prompted from "Skill of the Week" lessons.

Interventional arm

Eligibility Criteria

Age19 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years of age
  • Prior AYA cancer diagnosis
  • Completed primary treatment for their cancer
  • Score of 3 or above on the Distress Thermometer at the time of recruitment

You may not qualify if:

  • Individuals without legal capacity to give consent
  • Individuals who are not fluent in reading, writing, and speaking English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke Cancer Institute

Durham, North Carolina, 27710, United States

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Sophia K Smith, PhD, MSW

    Duke University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andrea Pires, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2024

First Posted

December 13, 2024

Study Start

June 13, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

May 6, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations